Axitinib and avelumab (AA) as first-line treatment of metastatic renal cell carcinoma (mRCC): A real-world outcome review in the Northwest of England, United Kingdom.

Authors

null

Jennifer Allison

Christie NHS Foundation Trust, Manchester, United Kingdom

Jennifer Allison , Natalie Charnley , Robert Stevenson , Tom Waddell , Manon Rhys Pillai

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Renal Cell Cancer

Track

Renal Cell Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 39, 2021 (suppl 6; abstr 294)

DOI

10.1200/JCO.2021.39.6_suppl.294

Abstract #

294

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters